Fu L - Search Results

1

Combinational therapy of crizotinib and afatinib for malignant pleural mesothelioma.

Huang L, Cai M, Zhang X, Wang F, Chen L, Xu M, Yang K, Chen Z, Wang X, Fu L. Huang L, et al. Among authors: fu l. Am J Cancer Res. 2017 Feb 1;7(2):203-217. eCollection 2017. Am J Cancer Res. 2017. PMID: 28337371 Free PMC article.

2

[Reversal of multidrug resistance of tumor cells by FG020327 and its mechanism].

Chen LM, Li YF, Zhang X, Yan SL, Liang YJ, Fu LW. Chen LM, et al. Ai Zheng. 2005 Feb;24(2):189-93. Ai Zheng. 2005. PMID: 15694031 Chinese.

3

Tetrandrine achieved plasma concentrations capable of reversing MDR in vitro and had no apparent effect on doxorubicin pharmacokinetics in mice.

Dai CL, Xiong HY, Tang LF, Zhang X, Liang YJ, Zeng MS, Chen LM, Wang XH, Fu LW. Dai CL, et al. Cancer Chemother Pharmacol. 2007 Oct;60(5):741-50. doi: 10.1007/s00280-007-0420-0. Epub 2007 Feb 2. Cancer Chemother Pharmacol. 2007. PMID: 17273824

4

Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.

Dai CL, Tiwari AK, Wu CP, Su XD, Wang SR, Liu DG, Ashby CR Jr, Huang Y, Robey RW, Liang YJ, Chen LM, Shi CJ, Ambudkar SV, Chen ZS, Fu LW. Dai CL, et al. Cancer Res. 2008 Oct 1;68(19):7905-14. doi: 10.1158/0008-5472.CAN-08-0499. Cancer Res. 2008. PMID: 18829547 Free PMC article.

5

Sensitization of ABCG2-overexpressing cells to conventional chemotherapeutic agent by sunitinib was associated with inhibiting the function of ABCG2.

Dai CL, Liang YJ, Wang YS, Tiwari AK, Yan YY, Wang F, Chen ZS, Tong XZ, Fu LW. Dai CL, et al. Cancer Lett. 2009 Jun 28;279(1):74-83. doi: 10.1016/j.canlet.2009.01.027. Epub 2009 Feb 18. Cancer Lett. 2009. PMID: 19232821

6

Cediranib (recentin, AZD2171) reverses ABCB1- and ABCC1-mediated multidrug resistance by inhibition of their transport function.

Tao LY, Liang YJ, Wang F, Chen LM, Yan YY, Dai CL, Fu LW. Tao LY, et al. Cancer Chemother Pharmacol. 2009 Oct;64(5):961-9. doi: 10.1007/s00280-009-0949-1. Epub 2009 Mar 3. Cancer Chemother Pharmacol. 2009. PMID: 19255759

7

Vandetanib (Zactima, ZD6474) antagonizes ABCC1- and ABCG2-mediated multidrug resistance by inhibition of their transport function.

Zheng LS, Wang F, Li YH, Zhang X, Chen LM, Liang YJ, Dai CL, Yan YY, Tao LY, Mi YJ, Yang AK, To KK, Fu LW. Zheng LS, et al. PLoS One. 2009;4(4):e5172. doi: 10.1371/journal.pone.0005172. Epub 2009 Apr 23. PLoS One. 2009. PMID: 19390592 Free PMC article.

8

Sensitization of ABCB1 overexpressing cells to chemotherapeutic agents by FG020326 via binding to ABCB1 and inhibiting its function.

Dai CL, Liang YJ, Chen LM, Zhang X, Deng WJ, Su XD, Shi Z, Wu CP, Ashby CR Jr, Akiyama S, Ambudkar SV, Chen ZS, Fu LW. Dai CL, et al. Biochem Pharmacol. 2009 Aug 15;78(4):355-64. doi: 10.1016/j.bcp.2009.04.023. Epub 2009 May 3. Biochem Pharmacol. 2009. PMID: 19410561 Free PMC article.

9

Bullatacin triggered ABCB1-overexpressing cell apoptosis via the mitochondrial-dependent pathway.

Liang YJ, Zhang X, Dai CL, Zhang JY, Yan YY, Zeng MS, Chen LM, Fu LW. Liang YJ, et al. J Biomed Biotechnol. 2009;2009:867123. doi: 10.1155/2009/867123. Epub 2009 Jul 21. J Biomed Biotechnol. 2009. PMID: 19639048 Free PMC article.

10

Reversal of P-gp-mediated multidrug resistance by Bromotetrandrine in vivo is associated with enhanced accumulation of chemotherapeutical drug in tumor tissue.

Chen LM, Liang YJ, Zhang X, Su XD, Dai CL, Wang FP, Yan YY, Tao LY, Fu LW. Chen LM, et al. Anticancer Res. 2009 Nov;29(11):4597-604. Anticancer Res. 2009. PMID: 20032409 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,699 results

Search Page

Filters